Hello, and welcome to the Kenvue fourth-quarter and full-year 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to ...

The FPX ETF, focused on high-growth IPOs, may not be the best investment choice in a high-interest rate environment. Read an analysis here.

Kenvue is the world’s largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson’s consumer segment, Kenvue spun off and went ...

Shares of Kenvue Inc. KVUE slipped 4.53% to $19.80 Thursday, on what proved to be an all-around mixed trading session for the ...

We believe Prestige is in fine financial health. At the end of fiscal 2024, the company had roughly $46 million in cash and equivalents with about $1.1 billion in long-term debt. Majority of debt was ...

Despite the large debt balance compared with its current level of cash, we expect healthy cash generation from Kenvue to meet all of its near-term financial obligations. Only $1.5 billion of debt is ...

The company has expanded adjusted gross margins by 200 basis points year-over-year to 60.4%, aided by productivity enhancements and cost-saving initiatives. Additionally, Kenvue is on track to achieve ...

Hello, and welcome to the Kenvue fourth-quarter and full-year 2024 earnings conference call. [Operator instructions] As a ...

Darra Gordon will replace Interim CEO Alexis Kantor next month to lead the national nonprofit focused on equality for LGBTQ+ families.

Kenvue posted mixed Q4 earnings, with in-line EPS but revenue below estimates, driven by challenges in its Skin Health and ...

Pure-play consumer health company Kenvue Inc. (KVUE) , while reporting weak fourth-quarter profit, in line with market, on Thursday ...

Recent developments in the health sector reveal challenges for key companies and organizations. Bristol Myers Squibb, Kenvue, ...